Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061529 · ClinicalTrials.gov registry record · Phase 3
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00061529: Completed Phase 3 study, sponsored by Alcon Research.
NCT00061529 is a Phase 3 study that has completed, run by Alcon Research. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00061529, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular hypertension.
Interventions
- DRUG Brimonidine Tartrate Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-01 |
| Est. Completion | 2004-07 |
| Phase | Phase 3 |
What the finished NCT00061529 record still lists
NCT00061529 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Brimonidine Tartrate Ophthalmic Solution is the first listed.
NCT00061529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00061529 about?
NCT00061529 is a clinical study titled "A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension". The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT00061529?
This trial is currently completed. It is a Phase 3 study. The study started on 2003-01. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00061529?
The interventions under investigation include: Brimonidine Tartrate Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT00061529?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia